Company Search:
Advanced Search
Sponsored Links
Salarius Pharmaceuticals Inc Company Snapshot
Salarius Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Salarius Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Xeris Pharmaceuticals Inc (2019 sales of $2.72 million of which 100% was Commercial physical), Aptinyx Inc ($3.67 million of which 100% was PHARMACEUTICAL), and Ocular Therapeutix Inc ($4.23 million of which 100% was Biopharmaceutical Preparations).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Salarius Pharmaceuticals Inc
  Stock Performance Chart for Salarius Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): .79
(Figures in U.S. Dollars)
1 Week -6.8%   13 Weeks -0.3%  
4 Weeks -39.7%   52 Weeks -84.0%  
Salarius Pharmaceuticals Inc Key Data:
  Ticker: SLRX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 3,465,055
(Year Ending Jan 2020).
Employees: 7
  Currency: U.S. Dollars Market Cap: 11,564,026
  Fiscal Yr Ends: December Shares Outstanding: 14,638,008
  Share Type: Common Closely Held Shares: 1,100,963
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.